Platelets are produced upon profound reorganization of mature megakaryocytes (MK) leading to proplatelet elongation and release into the blood stream, a process termed thrombopoiesis. This highly dynamic process requires microtubules (MT) reorganization by mechanisms that are still incompletely understood. Adenomatous polyposis coli (APC) is a microtubule plus-end tracking protein involved in the regulation of MT in a number of cell systems and its inactivation has been reported to alter hematopoiesis. The aim of our study was to investigate the role of APC in megakaryopoiesis and the final steps of platelet formation. Down-regulation of APC in cultured human MK by RNA interference increased endomitosis and the proportion of cells able to extend proplatelets (68.8% (shAPC1) and 52.5% (shAPC2) vs 28.1% in the control). Similarly an increased ploidy and amplification of the proplatelet network were observed in MK differentiated from Lin-cells of mice with APC-deficiency in the MK lineage. In accordance, these mice exhibited increased platelet counts when compared to wild type mice (1,323 ± 111 vs 919 ± 52 platelets/µL; n = 12 p 0.0033**). Their platelets had a normal size, ultrastructure and number of microtubules coils and their main functions were also preserved. Loss of APC resulted in lower levels of acetylated tubulin and decreased activation of the Wnt signaling pathway. Thus, APC appears as an important regulator of proplatelet formation and overall thrombopoiesis.
Immunofluorescence microscopy. Cultured MK were fixed in 4% paraformaldehyde (PFA) for 15 min and cytospun onto poly l-lysine-coated slides. The cells were then permeabilized for 15 min with 0.05% saponin in PBS containing 0.2% BSA and incubated sequentially for 30 min with 10 μg/mL of RAM.1-488 in the same buffer and the nuclei were counterstained with DAPI (Molecular Probes, Thermo Fisher Scientific, UK). The cells were washed thoroughly at each step. The slides were mounted in Mowiol (Mountant, Permafluor, Thermo Fisher Scientific, UK) for examination and proplatelet counting.
Differential interference contrast microscopy. Cultured MK were fixed at day 4 for 15 min in 4% PFA and cytospun onto poly l-lysine-coated slides. Differential interference contrast (DIC) images were acquired using a Leica DM4000B microscope (Leica Microsystems, Nanterre, France) with a 20×/0.6 NA lens coupled to a CoolSNAP photometrics HQ camera (Roper Scientific, Ottobrunn, Germany). The surface covered by MK bearing proplatelets was determined in 8 random fields by image analysis with Metamorph software (Molecular Devices, Downingtown, PA).
Transmission electron microscopy. Cells embedded in Epon were classically processed. Thin sections were cut, stained with uranyl acetate and lead citrate and examined under a CM120 transmission electron microscope (TEM) (FEI, The Netherlands) 17 . MK at stages I, II and III were counted manually on whole transversal sections as previously described 17 . To facilitate quantification, each square of the grids is defined as an area for examination (which equals 16,000 µm 2 ).
Western blotting. Cultured MK were collected at day 3 and subjected to enrichment on a BSA gradient (1.5-3%). Cells (4 × 10 6 cells) were washed in PBS, centrifuged at 100 g for 5 minutes and the pellets were resuspended in Laemmli buffer. Proteins from each sample were separated on 4-15% SDS gels (Bio-Rad, Hercules, CA), blotted onto PVDF membranes and incubated with specific primary antibodies. Specifically, anti-acetylated Tubulin Clone 6-11B-1 (Sigma Aldrich, Darmstadt, Germany), anti-α-Tubulin antibody clone DM1a (Sigma Aldrich, Darmstadt, Germany) and anti β-catenin clone 9581 (Cell signaling Technology, Danvers, MA) were used at 0.1 μg/mL, 1 µg/ mL, and at a dilution of 1/1000, respectively. Membranes were then washed and incubated for 1.5 hour at room temperature with 50 ng/mL peroxidase-conjugated goat anti-rabbit or with peroxidase-conjugated goat anti-mouse IgG (Jackson Immuno Research, PA, USA) and 50 ng/mL peroxidase conjugated goat anti GAPDH (Abcam, Paris, France) at room temperature and resolved by Clarity Western ECL Substrate (Bio-Rad, Hercules, CA). Membranes were visualized on a Chemidoc Imaging System (Bio-Rad, Hercules, CA). Processing for quantitative real-time RT-PCR. RNA preparations were extracted from mature MK (day 3) differentiated from bone marrow Lin-APC fl/fl progenitors or bone marrow Lin-WT progenitors transduced with shAPC using Rneasy mini kit (Qiagen, Courtaboeuf, France). The concentration of the RNA obtained was determined by using the 2100 BioAnalyzer (Agilent Technologies, Tokyo, Japan). Human Wnt related target genes expression was quantified by qRT-PCR analysis using the RT 2 Profiler Wnt signaling targets PCR array according to the manufacturer's recommendations (Qiagen, Courtaboeuf, France). The GAPDH gene was used as internal control and the 2 −ΔΔCt value was used to calculate the gene expression transcript levels.
Statistical analyses.
Results were expressed as the mean (±SEM) and statistical comparisons were performed using an unpaired, two-tailed Student's t test (Prism, GraphPad Software Inc., San Diego, CA) or a One-way ANOVA followed by a bonferroni post-test. P values of less than 0.05 were considered to be statistically significant.
Results

APC knockdown increases MK ploidy and proplatelet formation.
To address the involvement of APC in megakaryopoiesis, we first evaluated its expression in MK differentiated from mouse Lin-progenitors ( Fig. 1A) . APC transcripts were detected throughout the differentiation and maturation processes from D0 to D4 of culture. We then evaluated the effect of APC knockdown in in vitro differentiated MK. Lin-cells expressing GFP were transduced with lentiviral vectors containing shAPC1, shAPC2, or shGFP shRNA as a negative control. shGFP abolished GFP expression in 76% of the cells, establishing efficiency of the procedure (Fig. S1 ). Under these transduction conditions, shAPC1 and shAPC2 decreased the expression of APC by 29.2 ± 8.9 and 42.4 ± 8.3%, respectively, compared to shGFP control ( Fig. 1B,C) . shAPC2, the most active shRNA, was then chosen to evaluate the impact on megakaryopoiesis.
APC knockdown did not modify the number of MK (CD41 + CD42 + cells) generated at day 3 ( Fig. S2 ) but influenced their degree of maturation. Firstly, a larger fraction of these MK were of high ploidy in the shAPC2 condition versus control shGFP, with 38.2 ± 3.4 and 24.3 ± 1.4% cells being >8 N, respectively ( Fig. 2A ). Secondly, there was a 2.5 fold increase in the proportion of proplatelet-producing MK, from 28.1 ± 3.4% in the control (n = 647 cells) to 68.9 ± 3.7% for shAPC2 (n = 735 cells) ( Fig. 2C ). Thirdly, these proplatelets had a more complex dendritic organization. This resulted in an increased production of platelet-like elements which amounted to 7.9 ± 0.7 per MK in shAPC2 versus 4.5 ± 0.6 (n = 3; *p = 0.0255) in the control (Fig. 2D ).
Mice with APC-deficiency in the MK lineage exhibit increased platelet counts. The above exper-
iments suggested that APC deficiency could translate in vivo into an increased number of circulating platelets. Since a complete KO is known to be lethal, we generated a mouse strain with MK-restricted deficiency of APC by crossing Apc flox/flox mice with Pf4-Cre mice 12, 14 . Apc flox/flox ;Pf4-cre mice were obtained at the expected Mendelian frequency, but exhibited premature death due to colon tumor development as previously described 19 . We therefore exclusively used mice aged between 8-14 weeks. Analysis of hematologic parameters revealed a 50% increase in platelet count in Apc flox/flox ;Pf4-cre (1,323 ± 111.10 3 plts/μL; n = 12) compared to WT mice (919 ± 52.10 3 plts/ μL; n = 12; **p = 0.0033) ( Fig. 3A) , with no impact on platelet volume (Fig. 3B ), and on erythrocytes and white blood cells counts ( Fig. S3 ). APC-deficient platelets presented a normal ultrastructure with in particular a typical discoid shape and normal number and size of intracellular granules ( Fig. 3C ). Knowing the role of APC as a + TIP protein, the MT marginal band was observed in more detail but did not reveal any defect in the number and distribution of coils in APC-deficient platelets ( Fig. 3C ).
Loss of MK APC increases ploidisation without affecting the ultrastructure. The increased
number of circulating platelets in Apc flox/flox ;Pf4-cre mice could result from enhanced MK production or maturation. Analysis of the bone marrow showed an equivalent density of morphologically identified MK (1.4 ± 0.2 vs 1.3 ± 0.1 MK/µm 2 , n = 45 and 66) ( Fig. 3E ). In addition, the distribution between less and more mature MK (stages I-III) was not significantly different in wild type and Apc flox/flox ;Pf4-cre bone marrow ( Fig. 3F ). However, an increased ploidy level of bone marrow MK > 8 N (9.9 ± 2.8% vs 16.6 ± 5.6% n = 3-5) was observed in APC-deficient mice (Fig. 4A ) replicating the shRNA knockdown effects.
APC deficiency increases proplatelet network formation. When MK were differentiated from Linprogenitors, a similar proportion reached the proplatelet stage in Apc flox/flox ;Pf4-cre as compared to wild type mice (71 ± 8.7% n = 3 (754 cells) vs 73.3 ± 11.7% n = 3 (826 cells)) ( Fig. 4B ). However, APC-deficient proplatelets exhibited an increased branching and number of tips ( Fig. 4C ). This was illustrated by an enhanced surface coverage of the well (14.4 ± 1.5% vs 7.1 ± 0.7% n = 22; ***p < 0.0001, 8 random fields (156 µm 2 )) ( Fig. 4D ) and resulted in an increased number of platelets released in the culture medium (13.7 ± 1.9 vs 7.0 ± 0.7 plts/MK; n = 3; *p < 0.0301) ( Fig. 4E ).
Consequence of APC deficiency on MT acetylation and the Wnt/ β-catenin pathway. Previous
work has shown that cells lacking APC harbor MT that are less acetylated in certain areas possibly contributing to their abnormal shape 20 . We therefore explored whether this could also apply to APC-deficient MK. Western blot analysis at day 3 of MK differentiation showed a tendency of lower acetylated tubulin content in Apc flox/flox ;Pf4-cre mice with normal levels of total α tubulin ( Fig. 5A,B) .
A well reported consequence of APC deficiency is to prevent β-catenin degradation by the APC-Axin-GSK-3β complex. This was confirmed here in APC-deficient platelets in western blotting assay which exhibited high levels of β-catenin compared to control platelets (Fig. 5C ). This accumulation led us to analyze the modulation of the Wnt/β-catenin signaling pathway 21 . Decreased transcripts levels were observed in APC deficient mice for axin 2 and ctpb1, two negative regulators of the canonical pathway, and on the contrary an increased level of wnt11, Scientific REPoRTS | (2018) 8:15808 | DOI:10.1038/s41598-018-34118-y a component of the non-canonical pathway (Fig. S4A) . Similar tendencies were noted in MK from WT mice that had been transduced with shAPC2 ( Fig. S4B) . These results indicate that lack of APC expression results in better activation of the Wnt signaling pathway which could in turn support increased proplatelet formation. In support of this hypothesis we observed that inhibiting Wnt/β-catenin signaling, using an chemical compound FH535 22 , decreased the capacity of cultured MK to extend proplatelets (65.99 ± 3.02 WT; 33.38 ± 4.25 FH53) resulting in the decreased production of platelets in the culture medium by 60% on average (1.86.10 6 ± 0.22.10 6 WT; 0.78.10 6 ± 0.83.10 6 FH535) ( Fig. 5D ).
Discussion
The main finding of this study is that deficiency of APC in MK augments their capacity to extend proplatelets translating into an increased production of platelets. These effects were observed in cultured MK using an RNAi knockdown approach and in vivo in mice lacking APC in the megakaryocytic lineage. These results indicate a new role of this multifunctional protein as a negative regulator of the last stages of platelet biogenesis. Considering the possible mechanisms for the increased platelet production upon APC deficiency two major downstream components of APC signaling can be considered: the β-catenin pathway and microtubules. The implication of microtubules is strongly suggested by previous findings in neuronal cells. The increased capacity to extend proplatelets is reminiscent of the increased axonal branching of cortical neurons in APC conditional knockouts 23 . This later effect appeared to be independent of β-catenin and pointed to a MT-dependent role in neurons. Another parallel between platelet formation and neuron development is the observation that APC knockdown in dorsal root ganglion neurons leads to MT looping in the growth cone 11 , an unusual MT arrangement resembling that occurring during marginal band formation in proplatelet tips 4 . An additional analogy pertains to MT acetylation which was decreased in APC-deficient MK, similar to what has been observed in APC deficient fibroblasts 20 and is considered to reflect more dynamic MT. The role of tubulin acetylation on platelet biogenesis remains however unclear. Inhibitors of the main deacetylase HDAC6, which increase the level of MT acetylation, have shown an inhibitory effect on megakaryopoiesis in vitro and in vivo. However, a recent study by Messaoudi K et al. 24 indicates that this is mediated in human cells via acetylation of cortactin and not tubulin. A direct way to address the role of a decreased acetylation, as observed here in APC KO, would be to knock out ATAT1, the main acetylase in platelets, a strategy that is currently under evaluation. Considering possible mechanisms involving MT, APC can bind to MT plus ends and also interacts with EB1 and the formin mDia (DIAPH) to form a complex which stabilizes the MT growing ends 25 . APC marks the leading edge in adherent cells and favors the linear growth of preexisting MT 25 . This suggests that perturbation of the APC-EB1-mDia1 complex, by removing APC at late stages of MK maturation, could favor a dendritic growth of MT and expand the proplatelet network. Interestingly, RNAi knockdown of mDia1 in MK has been found to increase proplatelet formation similarly to APC knockdown 26 in line with the proposed MT-dependent mechanism. Additional partners of APC could also play a role such as CLIP-170 together with IQGAP1, which serve to link MT and actin at the leading edge of migrating cells 9, 10 . Finally, APC interacts with members of the kinesin family, adding to the array of possibilities for APC to modulate MT functions during proplatelet formation. The wnt/β-catenin pathway could also facilitate proplatelet formation in view of the marked increase in β-catenin in APC-deficient MK and platelets. In support of this, it has been reported that MK cultured in the presence of wnt3a, which stabilizes β-catenin, more effectively extend proplatelets 21 , but the mechanism remains Western blot analyses of tubulin acetylation in lysates from cultured MK (day 3) derived from WT mice and APC −/− mice using anti-acetylated tubulin clone 6-11B-1. A decreased level of acetylated tubulin is observed in cultured MK obtained from APC −/− mice and quantified compared to wild type control (n = 3, ns p = 0.11). (B) Western blot analyses of total α-tubulin using anti-α-tubulin antibody clone DM1a did not reveal differences between WT mice and APC −/− mice. (C) Western blot analyses using an anti-β-catenin antibody showed a dramatic increase in cellular β-catenin levels in APC −/− mice (n = 3, *p = 0.04). (D) Effect of two inhibitors of wnt/ β-catenin signaling on proplatelet formation (65.99 ± 3.02 WT; 33.38 ± 4.25 FH53; n = 3, **p = 0.0036) and platelet production (1.86.10 6 ± 0.22.10 6 WT; 0.78.10 6 ± 0.83.10 6 FH535, n = 3, *p = 0.02). Bar graph representing the mean ± SEM percentage of MK extending proplatelets and the mean number of platelet elements released from day 4 cultured MK. unclear. We indirectly addressed the hypothesis of a Wnt-β catenin involvement in promoting platelet formation using two well characterized inhibitors of this signaling pathway. We observed that they both inhibit the capacity of cultured MK to extend proplatelets and to produce platelets, results which would be in line with the hypothesis that an increased activity of this pathway would on the contrary promote MK maturation and platelet production. Wnt signaling is not limited to activate transcription of target genes and has also been proposed to regulate actin and MT stability and organization in other cells. For example, wnt3a increases the growth cone size in DRG neurons by a mechanism independent of transcription and acting through a β-catenin pathway directly signaling to the cytoskeleton 11 . A role of APC in hematopoiesis has been previously documented 12, 27 but our work provides the first indication of a specific role in the MK lineage. APC ablation in the hematopoietic lineage in Apc flox/flox ; Mx1-cre mice after pIpC injection, resulted in an exhaustion of the HSC pool due to increased cell cycle entry and apoptosis, and a block of multilineage differentiation. The only previous indication of a role of APC in MK has been a report of increased megakaryopoiesis in the spleen of Apc min/+ mice 28 , which reproduce a human mutation at codon 850 of APC. APC is a large and multidomain protein, and depending on the location of the truncation or mutation, different functional consequences could occur. Deletion of exon 14 as in the present study produces a truncated protein lacking the C-terminal domains including the binding sites for MT and EB1 and also for β-catenin. The Apc min/+ mice reproduces an antisense mutation resulting in haploinsufficiency of APC and it is not clear if the observed effects result from low protein expression of by production of abnormal forms of APC. In view of the multifunctional nature of APC, its capacity to regulate megakaryopoiesis could clearly occur through multiple mechanisms. Our study clearly indicates that it acts on platelet biogenesis by controlling the final stages of proplatelet formation. This has been shown in separate RNAi and knock out strategies targeting the megakaryocytic lineage. Clear analogies with results obtained in neuronal cells favor a mechanism related to the capacity of APC to modulate MT activity. The only models described to date interfering with MT (TUBB1 KO, MT depolymerization drugs) present with decreased platelet production. The APC-deficient mouse would therefore represent the first indication that platelet production can be positively modulated by acting on the microtubular cytoskeleton.
In conclusion, this study has presented evidence for the role of a non-motor MT associated protein (MAP) in regulating the final stages of MK maturation and platelet biogenesis. The unique mode of MT assembly during thrombopoiesis, leading to marginal band formation in circulating platelets, suggests that a particular set of additional MAPs might be required. Their identification could help us to better decipher the mechanisms of platelet formation and open ways to improve our capacity to produce platelets in vitro.
